Literature DB >> 16285333

The incidence of postoperative venous thrombosis among patients with ulcerative colitis.

O J O'Connor1, R A Cahill, W O Kirwan, H P Redmond.   

Abstract

BACKGROUND: Patients with Ulcerative Colitis (UC) have inherent prothrombotic tendencies. It is unknown whether this necessitates the use of additional perioperative anti-thrombotic prophylaxis when such patients require major surgery.
METHODS: The postoperative courses of 79 patients with UC undergoing 180 major abdominal and pelvic operations were examined for clinical and radiological evidence of venous thrombosis. Eighteen patients with Familial Adenomatous Polyposis (FAP) having surgery (35 operations) of similar magnitude were also studied. Standard anti-thrombosis prophylaxis was utilised in all patients.
RESULTS: Nine patients with UC were clinically suspected of developing postoperative venous thrombosis, but only three (3.8%) had their diagnosis confirmed radiologically (all had a pulmonary embolus). Therefore, the overall postoperative thrombosis rate, on an intention to treat basis, was 1.7% (3/180). No patient with FAP developed significant venous thrombosis.
CONCLUSION: Standard perioperative antithrombotic modalities are sufficient to maintain any potential increase in postoperative thrombotic risk at an acceptable level in patients with UC undergoing operative intervention.

Entities:  

Mesh:

Year:  2005        PMID: 16285333     DOI: 10.1007/bf03169142

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  11 in total

1.  Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease.

Authors:  G Novacek; W Miehsler; S Kapiotis; R Katzenschlager; W Speiser; H Vogelsang
Journal:  Am J Gastroenterol       Date:  1999-03       Impact factor: 10.864

2.  The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study.

Authors:  C N Bernstein; J F Blanchard; D S Houston; A Wajda
Journal:  Thromb Haemost       Date:  2001-03       Impact factor: 5.249

3.  Vascular complications of inflammatory bowel disease.

Authors:  R W Talbot; J Heppell; R R Dozois; R W Beart
Journal:  Mayo Clin Proc       Date:  1986-02       Impact factor: 7.616

4.  Anti-cardiolipin antibodies in patients with inflammatory bowel disease.

Authors:  B W Aichbichler; W Petritsch; G A Reicht; H H Wenzl; A J Eherer; T A Hinterleitner; P Auer-Grumbach; G J Krejs
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

5.  Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis.

Authors:  M Vecchi; E Sacchi; S Saibeni; G Meucci; L Tagliabue; F Duca; R De Franchis
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

6.  Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease.

Authors:  Elena M Faioni; Stefano Ferrero; Gessica Fontana; Umberto Gianelli; Michele M Ciulla; Maurizio Vecchi; Simone Saibeni; Eugenia Biguzzi; Nicoletta Cordani; Franca Franchi; Silvano Bosari; Marco Cattaneo
Journal:  Crit Care Med       Date:  2004-05       Impact factor: 7.598

7.  Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?

Authors:  W Miehsler; W Reinisch; E Valic; W Osterode; W Tillinger; T Feichtenschlager; J Grisar; K Machold; S Scholz; H Vogelsang; G Novacek
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

8.  Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden.

Authors:  L M Jackson; P J O'Gorman; J O'Connell; C C Cronin; K P Cotter; F Shanahan
Journal:  QJM       Date:  1997-03

9.  The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease.

Authors:  H A Liebman; N Kashani; D Sutherland; W McGehee; A L Kam
Journal:  Gastroenterology       Date:  1998-10       Impact factor: 22.682

10.  Rates of venous thrombosis after general surgery: combined results of randomised clinical trials.

Authors:  G A Colditz; R L Tuden; G Oster
Journal:  Lancet       Date:  1986-07-19       Impact factor: 79.321

View more
  6 in total

1.  Symptomatic pneumatosis intestinalis (including portal venous gas) after laparoscopic total colectomy.

Authors:  Aneela Shah; Hazar Al Furajii; Ronan A Cahill
Journal:  World J Gastrointest Endosc       Date:  2014-11-16

Review 2.  Inflammatory bowel disease: perioperative pharmacological considerations.

Authors:  Ajay Kumar; Moises Auron; Ashish Aneja; Franziska Mohr; Alok Jain; Bo Shen
Journal:  Mayo Clin Proc       Date:  2011-08       Impact factor: 7.616

3.  Physicians' perceptions of risks and practices in venous thromboembolism prophylaxis in inflammatory bowel disease.

Authors:  Justina J Sam; Charles N Bernstein; Roshan Razik; Reka Thanabalan; Geoffrey C Nguyen
Journal:  Dig Dis Sci       Date:  2012-10-07       Impact factor: 3.199

Review 4.  Inflammatory bowel disease and thromboembolism.

Authors:  Petros Zezos; Georgios Kouklakis; Fred Saibil
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 5.  Preoperative optimization of patients with inflammatory bowel disease undergoing gastrointestinal surgery: a systematic review.

Authors:  Marie Strøm Zangenberg; Nir Horesh; Uri Kopylov; Alaa El-Hussuna
Journal:  Int J Colorectal Dis       Date:  2017-10-19       Impact factor: 2.571

Review 6.  Venous thromboembolism in patients with inflammatory bowel disease: focus on prevention and treatment.

Authors:  Alfredo Papa; Viviana Gerardi; Manuela Marzo; Carla Felice; Gian Lodovico Rapaccini; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.